clofibric acid has been researched along with Anoxemia in 1 studies
Clofibric Acid: An antilipemic agent that is the biologically active metabolite of CLOFIBRATE.
clofibric acid : A monocarboxylic acid that is isobutyric acid substituted at position 2 by a p-chlorophenoxy group. It is a metabolite of the drug clofibrate.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gabano, E | 1 |
| Ravera, M | 1 |
| Trivero, F | 1 |
| Tinello, S | 1 |
| Gallina, A | 1 |
| Zanellato, I | 1 |
| Gariboldi, MB | 1 |
| Monti, E | 1 |
| Osella, D | 1 |
1 other study available for clofibric acid and Anoxemia
| Article | Year |
|---|---|
The cisplatin-based Pt(iv)-diclorofibrato multi-action anticancer prodrug exhibits excellent performances also under hypoxic conditions.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cisplatin; Clofibric Acid; Dose-Response Relatio | 2018 |